Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
13 10 2020
Historique:
pubmed: 26 9 2020
medline: 4 11 2020
entrez: 25 9 2020
Statut: ppublish

Résumé

As the COVID-19 pandemic continues, formulating targeted policy interventions that are informed by differential severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission dynamics will be of vital importance to national and regional governments. We develop an individual-level model for SARS-CoV-2 transmission that accounts for location-dependent distributions of age, household structure, and comorbidities. We use these distributions together with age-stratified contact matrices to instantiate specific models for Hubei, China; Lombardy, Italy; and New York City, United States. Using data on reported deaths to obtain a posterior distribution over unknown parameters, we infer differences in the progression of the epidemic in the three locations. We also examine the role of transmission due to particular age groups on total infections and deaths. The effect of limiting contacts by a particular age group varies by location, indicating that strategies to reduce transmission should be tailored based on population-specific demography and social structure. These findings highlight the role of between-population variation in formulating policy interventions. Across the three populations, though, we find that targeted "salutary sheltering" by 50% of a single age group may substantially curtail transmission when combined with the adoption of physical distancing measures by the rest of the population.

Identifiants

pubmed: 32973089
pii: 2010651117
doi: 10.1073/pnas.2010651117
pmc: PMC7568285
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

25904-25910

Subventions

Organisme : NICHD NIH HHS
ID : T32 HD040128
Pays : United States

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Lancet Respir Med. 2020 May;8(5):434-436
pubmed: 32203710
Am J Infect Control. 1997 Oct;25(5):424-5
pubmed: 9343628
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16118-16120
pubmed: 32576696
Science. 2020 Jun 26;368(6498):1481-1486
pubmed: 32350060
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
PLoS Comput Biol. 2017 Sep 12;13(9):e1005697
pubmed: 28898249
Euro Surveill. 2020 Jan;25(4):
pubmed: 32019669
Tumori. 2017 Jul 31;103(4):353-359
pubmed: 28574129
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
Percept Mot Skills. 2003 Dec;97(3 Pt 1):805-10
pubmed: 14738345
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S21-S30
pubmed: 31211103
Math Biosci. 2015 Aug;266:23-35
pubmed: 26037511
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Lancet. 2020 Mar 14;395(10227):e47
pubmed: 32113505
J Immunol. 2017 May 15;198(10):4046-4053
pubmed: 28373583
Lancet Infect Dis. 2020 Jul;20(7):773
pubmed: 32171390
Lancet Glob Health. 2020 May;8(5):e627-e630
pubmed: 32220289
Euro Surveill. 2020 Mar;25(12):
pubmed: 32234117
Sci Data. 2020 Mar 24;7(1):106
pubmed: 32210236
BMC Infect Dis. 2008 Mar 17;8:36
pubmed: 18366644

Auteurs

Bryan Wilder (B)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138; bwilder@g.harvard.edu milind_tambe@harvard.edu Maimuna.Majumder@childrens.harvard.edu.

Marie Charpignon (M)

Institute for Data, Systems, and Society, Massachusetts Institute of Technology, Cambridge, MA 02142.

Jackson A Killian (JA)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.

Han-Ching Ou (HC)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.

Aditya Mate (A)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.

Shahin Jabbari (S)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.

Andrew Perrault (A)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.

Angel N Desai (AN)

Department of Internal Medicine, Division of Infectious Diseases, University of California-Davis Health, Sacramento, CA 95817.

Milind Tambe (M)

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138; bwilder@g.harvard.edu milind_tambe@harvard.edu Maimuna.Majumder@childrens.harvard.edu.

Maimuna S Majumder (MS)

Department of Pediatrics, Harvard Medical School, Boston, MA 02115; bwilder@g.harvard.edu milind_tambe@harvard.edu Maimuna.Majumder@childrens.harvard.edu.
Computational Health Informatics Program, Boston Children's Hospital, Boston, MA 02115.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH